An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income CountriesJ. Connor Wells, Christopher M. Booth, Shubham Sharma et al.|JAMA Oncology|2021Cited by 165
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumoursC. Coyle, Ruth E. Langley, Fay Cafferty et al.|Contemporary Clinical Trials|2016Cited by 162
Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworksJoseph C. Del Paggio, Christopher M. Booth, C.S. Pramesh et al.|The Lancet Oncology|2017Cited by 147
Common Sense Oncology: outcomes that matterChristopher M. Booth, Bishal Gyawali, Manju Sengar et al.|The Lancet Oncology|2023Cited by 101
Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwideChandrakanth Are, Cheng Har Yip, Shilpa S. Murthy et al.|The Lancet Oncology|2023Cited by 87